Market Place
Sourcing Support
All News #Library
Biotech
Celltrion Spotlights Abpro`s ABP-102 at 44th JPM Conference
15 Jan 2026 //
GLOBENEWSWIRE
Abpro & Celltrion Gain FDA Clearance For Cancer Antibody ABP-102
06 Jan 2026 //
GLOBENEWSWIRE
Abpro Holdings Submits IND For Phase 1 Trial Of T Cell Engager
15 Dec 2025 //
GLOBENEWSWIRE
Abpro Extends Nasdaq Listing For Compliance And Strategy Pursuit
09 Dec 2025 //
GLOBENEWSWIRE
Abpro, Celltrion To Showcase Next-Gen HER2×CD3 T-Cell Engager
04 Nov 2025 //
GLOBENEWSWIRE
Abpro, Celltrion reveal data for ABP-102/CT-P72 at AACR 2025
27 Apr 2025 //
GLOBENEWSWIRE
Abpro to Present Preclinical Data on ABP-102/CT-P72 at AACR 2025
25 Mar 2025 //
GLOBENEWSWIRE
Abpro Statement on the Departure of Former CEO Ian Chan
10 Mar 2025 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.